Metabolomic profiling of asthma: Diagnostic utility of urine nuclear magnetic resonance spectroscopy

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 3, 2011, Pages 757-764.e6

  Saude, Erik J ^a   Skappak, Christopher D ^a   Regush, Shana ^a   Cook, Kim ^a   Ben Zvi, Amos ^a   Becker, Allan ^b   Moqbel, Redwan ^a,b   Sykes, Brian D ^a   Rowe, Brian H ^a   Adamko, Darryl J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Asthma; biomarkers; inflammation; metabolomics; NMR; urine

Indexed keywords

1 METHYLNICOTINAMIDE; 2 METHYLGLUTARIC ACID; 2 OXOGLUTARIC ACID; 3 HYDROXY 3 METHYLGLUTARIC ACID; 3 METHYLADIPATE; 4 AMINOHIPPURIC ACID; ACETONE; ACETYLCARNITINE; ACONITIC ACID; ADENINE; ADIPIC ACID; ALANINE; BIOLOGICAL MARKER; CREATINE; DIMETHYLAMINE; FORMIC ACID; FUMARIC ACID; GLUCOSE; GLYCOLIC ACID; IMIDAZOLE; INOSITOL; LACTIC ACID; OXALOACETIC ACID; PHENYLACETYLENE; PHENYLACETYLGLYCINE; PHENYLALANINE; TELE METHYLHISTAMINE; THREONINE; TRYPTOPHAN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADOLESCENT; AIRWAY; ALGORITHM; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE EXACERBATION; HUMAN; MAJOR CLINICAL STUDY; METABOLITE; METABOLOMICS; MODEL; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; PATIENT MONITORING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 79952309777     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.12.1077     Document Type: Article

References (53)

1. S.T. Holgate Pathogenesis of asthma Clin Exp Allergy 38 2008 872 897
2. D.R. Taylor, and I.D. Pavord Biomarkers in the assessment and management of airways diseases Postgrad Med J 84 2008 628 634 quiz 33
3. J.A. Nadel, J.F. Murray, and J.A. Nadel Textbook of respiratory medicine 2000 W.B. Saunders Philadelphia, PA
4. E.D. Fixman, A. Stewart, and J.G. Martin Basic mechanisms of development of airway structural changes in asthma Eur Respir J 29 2007 379 389 (Pubitemid 46231919)
5. Expert Panel report 3 (EPR3): guidelines for the diagnosis and management of asthma NHLBI produced publications 2007; section 3: overview and component 1: measures of assessment and monitoring, (452 K) 39.
6. C.E. Brightling, R.H. Green, and I.D. Pavord Biomarkers predicting response to corticosteroid therapy in asthma Treat Respir Med 4 2005 309 316 (Pubitemid 43127499)
7. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721 (Pubitemid 35447900)
8. F.E. Hargreave Quantitative sputum cell counts as a marker of airway inflammation in clinical practice Curr Opin Allergy Clin Immunol 7 2007 102 106 (Pubitemid 46095894)
9. N. Scichilone, A. Deykin, E. Pizzichini, V. Bellia, and R. Polosa Monitoring response to treatment in asthma management: food for thought Clin Exp Allergy 34 2004 1168 1177 (Pubitemid 39093054)
10. S.J. Szefler, H. Mitchell, C.A. Sorkness, P.J. Gergen, G.T. O'Connor, and W.J. Morgan Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial Lancet 372 2008 1065 1072
11. E.Y. Xu, W.H. Schaefer, and Q. Xu Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways Curr Opin Drug Discov Devel 12 2009 40 52
12. G.A. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery Metabolomics-based methods for early disease diagnostics Expert Rev Mol Diagn 8 2008 617 633
13. B.M. Beckwith-Hall, J.K. Nicholson, A.W. Nicholls, P.J. Foxall, J.C. Lindon, and S.C. Connor Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins Chem Res Toxicol 11 1998 260 272 (Pubitemid 28194349)
14. C. Godet, M. Hira, M. Adoun, M. Eugne, and R. Robert Rapid diagnosis of alcoholic ketoacidosis by proton NMR Intensive Care Med 2001 27
15. I.J. Forsythe, and D.S. Wishart Exploring human metabolites using the human metabolome database Curr Protoc Bioinformatics 2009 Chapter 14:Unit14 8
16. C. Skappak Ejs, K. Cook, B. Rowe, and D.J. Adamko The use of nuclear magnetic resonance analysis of urine in the diagnosis of asthma Am J Respir Crit Care Med 179 2009 A2531
17. A. Becker, C. Lemiere, D. Berube, L.P. Boulet, F.M. Ducharme, and M. FitzGerald Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003 CMAJ 173 2005 S3 S11
18. A.L. Kozyrskyj, K.T. HayGlass, A.J. Sandford, P.D. Pare, M. Chan-Yeung, and A.B. Becker A novel study design to investigate the early-life origins of asthma in children (SAGE study) Allergy 64 2009 1185 1193
19. E.J. Saude, C.M. Slupsky, and B.D. Sykes Optimization of NMR analysis of biological fluids for quantitative accuracy Metabolomics 2 2006 113 123 (Pubitemid 44473570)
20. E.J. Saude, and B.D. Sykes Urine stability for metabolomic studies: effects of preparation and storage Metabolomics 3 2007 19 27 (Pubitemid 46453528)
21. E.J. Saude, D. Adamko, B.H. Rowe, T. Marrie, and B.D. Sykes Variation of metabolites in normal human urine Metabolomics 3 2007 439 451 (Pubitemid 350090674)
22. E.M. Lenz, J. Bright, I.D. Wilson, A. Hughes, J. Morrisson, and H. Lindberg Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects J Pharm Biomed Anal 36 2004 841 849 (Pubitemid 39469425)
23. E.J. Saude, I.P. Obiefuna, R.L. Somorjai, F. Ajamian, C. Skappak, and T. Ahmad Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance Am J Respir Crit Care Med 179 2009 25 34
24. C. Wojnarowski, B. Roithner, D.Y. Koller, G. Halmerbauer, C. Gartner, and E. Tauber Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study Clin Exp Allergy 29 1999 926 932 (Pubitemid 29317803)
25. C. Severien, A. Artlich, S. Jonas, and G. Becher Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma Eur Respir J 16 2000 588 592
26. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732 (Pubitemid 37328811)
27. J. Aragones, P. Fraisl, M. Baes, and P. Carmeliet Oxygen sensors at the crossroad of metabolism Cell Metab 9 2009 11 22
28. J.P. Shockcor, and E. Holmes Metabonomic applications in toxicity screening and disease diagnosis Curr Top Med Chem 2 2002 35 51
29. J. Azmi, J. Connelly, E. Holmes, J.K. Nicholson, R.F. Shore, and J.L. Griffin Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition Biomarkers 10 2005 401 416
30. D.L. Nelson, A.L. Lehninger, and M.M. Cox Lehninger principles of biochemistry 5th ed. 2008 W.H. Freeman New York
31. G. Leipnitz, B. Seminotti, J. Haubrich, M.B. Dalcin, K.B. Dalcin, and A. Solano Evidence that 3-hydroxy-3-methylglutaric acid promotes lipid and protein oxidative damage and reduces the nonenzymatic antioxidant defenses in rat cerebral cortex J Neurosci Res 86 2008 683 693 (Pubitemid 351204483)
32. A. Kumps, P. Duez, and Y. Mardens Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table Clin Chem 48 2002 708 717 (Pubitemid 34439102)
33. D.F. Pauly, and C.J. Pepine The role of carnitine in myocardial dysfunction Am J Kidney Dis 41 2003 S35 S43
34. T. Oka, T. Itoi, N. Terada, H. Nakanishi, R. Taguchi, and K. Hamaoka Change in the membranous lipid composition accelerates lipid peroxidation in young rat hearts subjected to 2 weeks of hypoxia followed by hyperoxia Circ J 72 2008 1359 1366
35. R.A. Brown, D. Spina, and C.P. Page Adenosine receptors and asthma Br J Pharmacol 153 2008 S446 S456
36. J.D. Benedict, H.J. Kalinsky, L.A. Scarrone, A.R. Wertbeim, and D. Stetten Jr. The origin of urinary creatine in progressive muscular dystrophy J Clin Invest 34 1955 141 145
37. C. Fitch, and D. Sinton A study of creatine metabolism in diseases causing muscle wasting J Clin Invest 43 1964 444 452
38. P.R. Baker, S.D. Cramer, M. Kennedy, D.G. Assimos, and R.P. Holmes Glycolate and glyoxylate metabolism in HepG2 cells Am J Physiol Cell Physiol 287 2004 C1359 C1365
39. E. Bekier, J. Wyczolkowska, H. Szyc, and C. Maslinski The inhibitory effect of nicotinamide on asthma-like symptoms and eosinophilia in guinea pigs, anaphylactic mast cell degranulation in mice, and histamine release from rat isolated peritoneal mast cells by compound 48-80 Int Arch Allergy Appl Immunol 47 1974 737 748
40. W. Wu, M.K. Samoszuk, S.A. Comhair, M.J. Thomassen, C.F. Farver, and R.A. Dweik Eosinophils generate brominating oxidants in allergen-induced asthma J Clin Invest 105 2000 1455 1463 (Pubitemid 30322411)
41. E.J. Saude, P. Lacy, S. Musat-Marcu, D.C. Mayes, J. Bagu, and S.F. Man NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis Magn Reson Med 52 2004 807 814 (Pubitemid 39314983)
42. F. Nishiwaki, K. Kuroda, Y. Inoue, and G. Endo Determination of histamine, 1-methylhistamine and N-methylhistamine by capillary electrophoresis with micelles Biomed Chromatogr 14 2000 184 187 (Pubitemid 30255905)
43. S. Takei, A. Shimago, M. Iwashita, T. Kumamoto, K. Kamuro, and K. Miyata Urinary N-methylhistamine in asthmatic children receiving azelastine hydrochloride Ann Allergy Asthma Immunol 78 1997 492 496 (Pubitemid 27215391)
44. V. Stephan, A. Zimmermann, J. Kuhr, and R. Urbanek Determination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions J Allergy Clin Immunol 86 1990 862 868
45. P. Tan, and A. Bharath Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases Expert Opin Ther Targets 2009
46. S.O. Odemuyiwa, A. Ghahary, Y. Li, L. Puttagunta, J.E. Lee, and S. Musat-Marcu Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase J Immunol 173 2004 5909 5913 (Pubitemid 39487742)
47. A. Becker, C. Lemiere, D. Berube, L.P. Boulet, F.M. Ducharme, and M. FitzGerald Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003 CMAJ 173 2005 S3 S11
48. E.J. Saude, C.M. Slupsky, and B.D. Sykes Optimization of NMR analysis of biological fluids for quantitative accuracy Metabolomics 2 2006 113 123 (Pubitemid 44473570)
49. E.J. Saude, and B.D. Sykes Urine stability for metabolomic studies: effects of preparation and storage Metabolomics 3 2007 19 27 (Pubitemid 46453528)
50. E.J. Saude, D. Adamko, B.H. Rowe, T. Marrie, and B.D. Sykes Variation of metabolites in normal human urine Metabolomics 3 2007 439 451 (Pubitemid 350090674)
51. E.M. Lenz, J. Bright, I.D. Wilson, A. Hughes, J. Morrisson, and H. Lindberg Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects J Pharm Biomed Anal 36 2004 841 849 (Pubitemid 39469425)
52. A. Kumar, R.R. Ernst, and K. Wuthrich A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules Biochem Biophys Res Commun 95 1980 1 6
53. E.J. Saude, I.P. Obiefuna, R.L. Somorjai, F. Ajamian, C. Skappak, and T. Ahmad Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance Am J Respir Crit Care Med 179 2009 25 34